The family hopes 2021 will see completion of a clinical trial set to revolutionise treatment of severe depression.
Tue, 25 May 2021
Category: Make & Sell
Approx. $420 million
See all profiles, rankings and feature articles on The NBR List 2021 home page.
Douglas Pharmaceuticals managing director Jeff Douglas’s high point of 2021 will be the completion of a clinical trial that is set to revolutionise the treatment
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
